SYVAXUM Trademark

Trademark Overview


On Thursday, February 6, 2014, a trademark application was filed for SYVAXUM with the United States Patent and Trademark Office. The USPTO has given the SYVAXUM trademark a serial number of 79143870. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 14, 2021. This trademark is owned by NOVARTIS AG. The SYVAXUM trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
syvaxum

General Information


Serial Number79143870
Word MarkSYVAXUM
Filing DateThursday, February 6, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 14, 2021
Registration Number4626863
Registration DateTuesday, October 28, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2014

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Monday, July 11, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, May 16, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, May 16, 2022INVALIDATION PROCESSED
Friday, January 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 14, 2021CANCELLED SECTION 71
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Tuesday, December 2, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 2, 2014FINAL DISPOSITION PROCESSED
Thursday, November 27, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, October 28, 2014REGISTERED-PRINCIPAL REGISTER
Friday, September 19, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, May 20, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, May 16, 2014NOTIFICATION PROCESSED BY IB
Tuesday, May 6, 2014PUBLISHED FOR OPPOSITION
Thursday, May 1, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 30, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 16, 2014NOTICE OF PUBLICATION
Wednesday, March 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 25, 2014ASSIGNED TO EXAMINER
Tuesday, March 18, 2014APPLICATION FILING RECEIPT MAILED
Friday, March 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 13, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords


syvaxum human vaccines